Oncimmune Holdings plc
ONC.L · LSE
8/31/2024 | 2/29/2024 | 8/31/2023 | 2/28/2023 | |
|---|---|---|---|---|
| Market Cap | £13 | £16 | £17 | £25 |
| - Cash | £1 | £1 | £3 | £1 |
| + Debt | £5 | £5 | £5 | £10 |
| Enterprise Value | £17 | £20 | £19 | £34 |
| Revenue | £2 | £1 | £0 | £1 |
| % Growth | 30.9% | 4,135.7% | -97.5% | – |
| Gross Profit | £1 | £0 | £0 | £0 |
| % Margin | 49.9% | 38.4% | 100% | 30.6% |
| EBITDA | -£2 | -£1 | -£1 | -£3 |
| % Margin | -150.8% | -50.9% | -2,628.6% | -239.6% |
| Net Income | -£3 | -£1 | £8 | -£4 |
| % Margin | -162.8% | -92.7% | 29,142.9% | -360.9% |
| EPS Diluted | -0.034 | -0.015 | 0.11 | -0.058 |
| % Growth | -130.4% | -113.5% | 289.7% | – |
| Operating Cash Flow | -£1 | -£2 | -£4 | -£3 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£1 | -£2 | -£4 | -£3 |